等级
certified reference material
质量水平
形式
liquid
特点
(Snap-N-Spike®)
包装
ampule of 1 mL
制造商/商品名称
Cerilliant®
浓度
2.0 mg/mL in methanol
技术
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
应用
clinical testing
格式
single component solution
储存温度
−20°C
InChI
1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1
InChI key
BCEHBSKCWLPMDN-MGPLVRAMSA-N
一般描述
Voriconazole, sold under the trade name Vfend®, is a triazole antifungal drug prescribed for treatment of serious, invasive fungal infections. This certified Snap-N-Spike® Solution is suitable as starting material for linearity standards, calibrators, or controls for therapeutic drug monitoring or clinical and diagnostic testing of voriconazole in patient blood, serum, or plasma samples by HPLC or LC-MS/MS.
应用
- Solubilization and antifungal activity enhancement: Research highlighted a synthetic citric crosslinked beta-cyclodextrin derivative designed to improve the solubilization and antifungal effectiveness of voriconazole. The study demonstrated enhanced solubility and reduced cytotoxicity, broadening its potential applications in antifungal drug formulation (Soe et al., 2023).
- Rapid quantitative plasma detection: A study developed a method using surface-enhanced Raman scattering to rapidly and quantitatively detect voriconazole in human plasma. This technique supports its use in pharmacokinetic and metabolism research, providing a rapid assessment tool for therapeutic monitoring (Liu et al
法律信息
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Vfend is a registered trademark of Pfizer, Inc.
相关产品
产品编号
说明
价格
警示用语：
Danger
危险分类
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
靶器官
Eyes,Central nervous system
WGK
WGK 2
闪点(°F)
closed cup
闪点(°C)
closed cup
法规信息
危险化学品
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门